Publications by authors named "L Finn"

Purpose: This article reports on a service evaluation of a domestic abuse intervention for hospital-based cancer professionals in two sites. The core component was a training and monitoring process, which hospital-based domestic abuse coordinators led. This role was adapted from a generic hospital role to be cancer specific.

View Article and Find Full Text PDF

We present the first case of a dupilumab-induced hyperinflammatory state in the setting of underlying eosinophilic esophagitis characterized by multisystem granulomatous inflammation. Although clinical trial data and subsequent real-world experience support dupilumab as a highly effective therapy for eosinophilic esophagitis, close monitoring for development of adverse symptoms following initiation remains paramount.

View Article and Find Full Text PDF
Article Synopsis
  • A study conducted in Los Angeles County assessed the effectiveness of the JYNNEOS vaccine against symptomatic mpox among men aged 18 and older who were eligible for vaccination between May 2022 and January 2023.
  • Out of 2,171 confirmed mpox cases, 93% were unvaccinated, while the vaccine effectiveness was found to be 69% for partially vaccinated individuals and 84% for those fully vaccinated.
  • Additionally, the vaccine offered different levels of protection based on HIV status, with fully vaccinated people living with HIV showing 72% effectiveness compared to 88% for those without HIV.
View Article and Find Full Text PDF

The etiologies of podocyte dysfunction that lead to pediatric nephrotic syndrome (NS) are vast and vary with age at presentation. The discovery of numerous novel genetic podocytopathies and the evolution of diagnostic technologies has transformed the investigation of steroid-resistant NS while simultaneously promoting the replacement of traditional morphology-based disease classifications with a mechanistic approach. Podocytopathies associated with primary and secondary steroid-resistant NS manifest as diffuse mesangial sclerosis, minimal change disease, focal segmental glomerulosclerosis, and collapsing glomerulopathy.

View Article and Find Full Text PDF